Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
UNLABELLED: Tumor-derived OPG has recently been shown to protect prostate cancer cells from apoptosis. This study has confirmed that bone marrow stromal cell-derived OPG also suppresses cytokine-induced apoptosis in this tumor type, suggesting that it may be the presence of bone-derived OPG that is...
Main Authors: | Nyambo, R, Cross, N, Lippitt, J, Holen, I, Bryden, G, Hamdy, F, Eaton, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
by: Nyambo, R, et al.
Published: (2004) -
Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
by: Cross, N, et al.
Published: (2007) -
Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
by: Papageorgiou, M, et al.
Published: (2005) -
Cells of the bone marrow microenvironment protect myeloma cells from apoptosis induced by TRAIL but not by agonists of TRAIL death receptors.
by: Locklin, R, et al.
Published: (2005) -
Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
by: Locklin, R, et al.
Published: (2007)